透过基因疗法进行端粒回收作为4型心综合征的有益策略
Danshu Xie1, Chenguang Wang2, Xin Wan2
1Department of Nephrology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China.
Kidney international
|February 20, 2026
概括
使用端粒酶逆转录酶 (modhTERT) 的基因疗法在4型心综合征 (CRS4) 模型中成功逆转心力衰竭. 这种新的方法为慢性病患者的心血管死亡率提供了潜在的治疗方法.
科学领域:
- 心血管生物学 心血管生物学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 分子医学是分子医学.
背景情况:
- 4型心综合征 (CRS4) 涉及由慢性病 (CKD) 驱动的心力衰竭,导致高心血管死亡率.
- 慢性病患者的短端粒与增加的死亡率相关,目前的治疗方法有限.
- 研究端粒长度和端粒酶活性对于理解和治疗CRS4至关重要.
研究的目的:
- 在CRS4模型中评估过度表达端粒酶逆转录酶 (modhTERT) 的治疗潜力.
- 评估 modhTERT 对心脏功能,结构和线粒体健康的影响CRS4.
- 为了确定 modhTERT 是否可以在CKD模型中改善功能.
主要方法:
- 设计了腺相关病毒9 (AAV9) 基因疗法 (JV101) 以在心脏托罗邦素T促进体控制下提供 modhTERT.
- 在体内 (5/6瘤切除术, ангиотензин II - 高盐 - 瘤切除术模型) 和体内 (人体诱导多能干细胞衍生心肌细胞) CRS4 模型中均使用.
- 评估心脏功能,缩,纤维化,线粒体功能,端粒长度和功能 (血液尿素).
主要成果:
- 在CRS4小鼠模型中, modhTERT过度表达恢复了心肌端粒,逆转了心脏功能障碍,增高,纤维化和线粒体功能障碍.
- modhTERT提供了长期和持久的心脏功能障碍逆转,优于β-阻断剂.
- 在CKD模型中,JV101改善了功能,而 modhTERT在暴露于CKD相关毒素的人类心肌细胞中逆转了端粒缩短和收缩功能障碍.
结论:
- 使用 modhTERT 的端粒回收基因疗法证明了治疗CRS4.4的概念证明.
- modhTERT有效地向心肌端粒,并逆转CRS4的关键病理特征.
- 这种方法有望解决与晚期CKD相关的高心血管死亡率.
相关概念视频
Telomeres and Telomerase
27.6K
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
27.6K
Telomeres and Telomerase
7.5K
7.5K
Replicative Cell Senescence
4.5K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.5K
Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Replication in Eukaryotes
18.0K
In eukaryotic cells, DNA replication is highly conserved and tightly regulated. Multiple linear chromosomes must be duplicated with high fidelity before cell division, so there are many proteins that fulfill specialized roles in the replication process. Replication occurs in three phases: initiation, elongation, and termination, and ends with two complete sets of chromosomes in the nucleus.
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
18.0K
Replication in Eukaryotes
206.2K
Overview
206.2K


